Relationship of Smoking and Fibrosis in Patients With Chronic Hepatitis C

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 6, 2006, Pages 797-801

  Dev, Anouk ^a   Patel, Keyur ^a,b   Conrad, Andrew ^c   Blatt, Lawrence M ^d   McHutchison, John G ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SCRIPPS CLINIC   (United States)

^c National Genetics Institute   (United States)

^d InterMune Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VIRUS RNA;

ADULT; ARTICLE; CIGARETTE SMOKING; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROGENESIS; GENOTYPE; HEPATITIS C; HUMAN; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; VIRUS INFECTION;

ADULT; FEMALE; FIBROSIS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; RECEPTOR PROTEIN-TYROSINE KINASES; SEX FACTORS; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33744738225     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.03.019     Document Type: Article

References (27)

1. Poynard T., Ratziu V., Benmanou Y., et al. Fibrosis in patients with chronic hepatitis C. detection and significance. Semin Liver Dis 20 (2000) 47-55
2. De Torres M., and Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol 2 (2003) 5-11
3. Monto A., Patel K., Bostrom A., et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 39 (2004) 826-834
4. Corrao G., Lepore A.R., Torchio P., et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 10 (1994) 657-664
5. Pessione F., Ramond M.J., Njapoum C., et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34 (2001) 121-125
6. Hezode C., Lonjon I., Roudot-Thoraval F., et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 52 (2003) 126-129
7. Gogo A.R., Cho C.H., and Yuen S.T. The cytotoxic effect of nicotine on the liver and its modulation of hepatotoxicity induced by carbon tetrachloride in rats. Eur J Gastroenterol Hepatol 5 (1993) 859-865
8. Öz Bölükbas F.F., Kabasakal L., Bölükbas C., et al. Hepatocyte damage caused by nicotine alone and in combination with alcohol (abstr L0493). Gastroenterology 114 (1998) A1318
9. Geng Y., Savage S.M., Razani-Boroujerdi S., et al. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 156 (1996) 2384-2390
10. Giannelli G., Quaranta V., and Antonaci S. Tissue remodelling in liver diseases. Histol Histopathol 18 (2003) 1267-1274
11. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
12. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
13. Semenza G.L. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54 (2003) 17-28
14. Rosmorduc O., Wendum D., Corpechot C., et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155 (1999) 1065-1073
15. Corpechot C., Barbu V., Wendum D., et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35 (2002) 1010-1021
16. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
17. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol 280 (2001) C1358-C1366
18. Wang D., Donner D.B., and Warren R.S. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. J Biol Chem 275 (2000) 15905-15911
19. Martinez-Hernandez A., and Amenta P. The extracellular matrix in hepatic regeneration. FASEB J 9 (1995) 1401-1410
20. Ankoma-Sey V., Matli M., Chang K., et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 17 (1998) 115-121
21. Shimoda K., Mori M., Shibuta K., et al. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma. Int J Oncol 14 (1999) 353-359
22. Takahashi M., Yoshimoto T., and Kubo H. Molecular mechanisms of lymphangiogenesis. Int J Hematol 80 (2004) 29-34
23. Benowitz N.L. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther 32 (1982) 758-764
24. Perret R., Froehlich F., Lavanchy D., et al. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis. Alcohol Clin Exp Res 21 (1997) 1337-1342
25. Yildiz D., Ercal N., and Armstrong D.W. Nicotine enantiomers and oxidative stress. Toxicology 130 (1998) 155-165
26. Waltenberger J., Claesson-Welsh L., Siegbahn A., et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269 (1994) 26988-26995
27. Yoshiji H., Kuriyama S., Yoshii J., et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52 (2003) 1347-1354